Significance of TP53 Mutational Status-Associated Signature in the Progression and Prognosis of Endometrial Carcinoma

Figure 7

Mutational landscape associated with the TP53 mutational status-associated signature. (a) Differences in TMB between the high- and low-risk groups. (b) Differences in TMB between EC patients with TP53 mutation or not in the high-risk group. (c) Differences in TMB between EC patients with TP53 mutation or not in the low-risk group. (d) Sankey diagram showed the relationship between risk score, TP53 mutational status, TMB, and survival status. (e) Mutational landscape associated with the TP53-associated signature.

(a)

(b)

(c)

(d)

(e)